Published in Am J Hum Genet on March 01, 1997
Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet (2004) 1.55
Satellog: a database for the identification and prioritization of satellite repeats in disease association studies. BMC Bioinformatics (2005) 0.97
Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. J Intellect Disabil Res (2004) 0.87
Statistical evaluation of age-at-onset anticipation: a new test and evaluation of its behavior in realistic applications. Am J Hum Genet (1998) 0.85
Heritability of schizophrenia and major affective disorder as a function of age, in the presence of strong cohort effects. Eur Arch Psychiatry Clin Neurosci (2005) 0.84
Paternal transmission and anticipation in schizophrenia. Am J Med Genet (1998) 0.81
Progress on the genetics of schizophrenia. J Psychiatry Neurosci (1998) 0.78
The French concept of "psychose hallucinatoire chronique" -a preliminary form of schizophrenia? The role of late-life psychosis in the anticipation hypothesis of schizophrenia. Dialogues Clin Neurosci (2001) 0.75
Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36
The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry (1993) 3.61
Anticipation in bipolar affective disorder. Am J Hum Genet (1993) 2.44
Anticipation in myotonic dystrophy: fact or fiction? Brain (1989) 2.41
Anticipation in Huntington's disease is inherited through the male line but may originate in the female. J Med Genet (1988) 2.37
Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A (1995) 2.18
Evidence for anticipation in schizophrenia. Am J Hum Genet (1994) 1.85
Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease. Am J Hum Genet (1995) 1.84
Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet (1993) 1.71
Expanded CAG repeats in schizophrenia and bipolar disorder. Nat Genet (1995) 1.66
Reproductive fitness in familial schizophrenia. Schizophr Res (1996) 1.40
Establishing the onset of psychotic illness. Am J Psychiatry (1993) 1.30
Imprinting and anticipation. Are they relevant to genetic studies of schizophrenia? Br J Psychiatry (1994) 1.20
The significance of age of onset for schizophrenia. Schizophr Bull (1992) 1.11
CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset. Hum Mol Genet (1995) 1.03
The clinical manifestation of mental disorder in Huntington's disease: a retrospective case record study of disease progression. Acta Psychiatr Scand (1991) 0.96
Late paraphrenia and its bearing on the aetiology of schizophrenia. Acta Psychiatr Scand (1963) 0.95
Estimating familial effects on age at onset and liability to schizophrenia. I. Results of a large sample family study. Genet Epidemiol (1990) 0.95
Mixed-model segregation analysis of schizophrenia in the Lindelius Swedish pedigrees. Behav Genet (1990) 0.92
Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders. Hum Mol Genet (1996) 0.92
Gender differences in age at onset of schizophrenia. Br J Psychiatry (1994) 0.89
Patterns of illness in parent-child pairs both hospitalized for either schizophrenia or a major mood disorder. Psychiatry Res (1991) 0.89
Familial psychiatric presentation of Huntington's disease. J Med Genet (1996) 0.89
Triplet repeats in clinical subtypes of schizophrenia: variation at the DRPLA (B 37 CAG repeat) locus is not associated with periodic catatonia. J Neural Transm Gen Sect (1994) 0.87
Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum (1997) 2.40
Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum (1998) 1.73
Premature death in adults with 22q11.2 deletion syndrome. J Med Genet (2009) 1.42
Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol (1995) 1.23
Bronchioloalveolar carcinoma: two clinical entities with one pathologic diagnosis. AJR Am J Roentgenol (1978) 1.02
Genetic screening and ethics: European perspectives. J Med Philos (1998) 0.98
Psychopathology and quality of life in schizophrenia. J Psychiatry Neurosci (1997) 0.95
Chromosomal aberrations and schizophrenia. Autosomes. Br J Psychiatry (1992) 0.93
Elevated rates of schizophrenia in a familial sample with mental illness and intellectual disability. J Intellect Disabil Res (2004) 0.87
Postmaturity in a genetic subtype of schizophrenia. Acta Psychiatr Scand (2003) 0.87
Did the pattern of practice in the prescription of palliative radiotherapy for the treatment of uncomplicated bone metastases change between 1999 and 2005 at the rapid response radiotherapy program? Clin Oncol (R Coll Radiol) (2008) 0.81
Angiographic management of arteriocolic fistulae. Cardiovasc Intervent Radiol (1986) 0.79
A measure of the 'sick' label in psychiatric disorder and physical illness. Soc Sci Med (1987) 0.78
A young-child nutrition programme in rural Jamaica. Lancet (1973) 0.78
Increased head circumference in schizophrenia. Biol Psychiatry (1996) 0.77
Exercise and breast cancer: review and critical analysis of the literature. Can J Appl Physiol (1994) 0.77
Comparison of hemodynamic responses to social and nonsocial stress: evaluation of an anger interview. Psychophysiology (2001) 0.76
Value of ecological analysis. Can J Public Health (1998) 0.75
[General practitioners' attitude to prescription of psychopharmaceuticals. Autonomy versus paternalism, education and understanding of disease]. Ugeskr Laeger (1991) 0.75
[Health policy. Minister's shift signifies a shift in course. Government's prevention program]. Sygeplejersken (1989) 0.75
The psychological evaluation of profoundly retarded children with the use of concrete reinforcers. J Psychol (1971) 0.75
Euroscreen 2: towards community policy on insurance, commercialization and public awareness. J Med Philos (2001) 0.75